I love these parts
The June quarter is traditionally the strongest of the financial year for Biome and the company
reports that the strong growth in FY24 has continued in Q4 with record sales revenue for April and
May.
Biome expects to report a second consecutive quarter of positive underlying operating cashflow and
EBITDA for Q4 FY24
Draw your own conclusions but that means April and May 2024 have been stellar - hard to see how/why June will not also be stellar in terms of sales
Onwards and upwards as we continue grow sales both locally and now are expanding into UK and Canada and logically more new country markets to follow.
(not to mention strong new product lines coming on line as we grow)
Good luck all holders
- Forums
- ASX - By Stock
- Ann: Biome expects to exceed FY24 forecast
I love these partsThe June quarter is traditionally the...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
-0.035(5.43%) |
Mkt cap ! $133.6M |
Open | High | Low | Value | Volume |
64.0¢ | 65.0¢ | 61.0¢ | $304.0K | 488.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 61.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.5¢ | 4100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 0.610 |
5 | 27011 | 0.605 |
12 | 120025 | 0.600 |
1 | 8386 | 0.595 |
2 | 15364 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.615 | 4100 | 1 |
0.620 | 3644 | 1 |
0.625 | 22882 | 2 |
0.630 | 45087 | 3 |
0.640 | 4500 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online